重组人促甲状腺激素在甲状腺疾病诊治中的应用

被引:5
作者
关海霞 [1 ]
陆汉魁 [2 ]
机构
[1] 中国医科大学附属第一医院内分泌科、内分泌研究所、辽宁省内分泌疾病重点实验室
[2] 上海交通大学附属第六人民医院核医学科
关键词
促甲状腺激素; 重组; 甲状腺疾病; 发展趋势;
D O I
暂无
中图分类号
R817.4 [在诊断上的应用]; R581 [甲状腺疾病];
学科分类号
摘要
重组人TSH(rhTSH)于1998年在国外进入临床应用,其临床适应证由辅助DTC患者的随访检查和检测逐渐扩展到辅助131I清除手术后残留甲状腺组织。近期研究表明,rhTSH在辅助131I治疗DTC转移灶、辅助131I治疗非毒性结节性甲状腺肿、提高18F-FDG PET对甲状腺癌的诊断效能及对先天性甲状腺功能减退症的病因鉴别诊断等多方面亦有应用潜力。
引用
收藏
页码:311 / 314
相关论文
共 10 条
  • [1] Recombinant human TSH (rhTSH) in 2009: new perspectives in diagnosis and therapy[J] . Molinaro,E,Viola,D,Passannanti,P,Agate,L,Lippi,F,Ceccarelli,C,Pinchera,A,Elisei,R. The Quarterly Journal of Nuclear Medicine and Molecular Imaging . 2009 (5)
  • [2] Recombinant human thyroid stimulating hormone in 2008: focus on thyroid cancer management[J] . Kathryn Schuff,Ann Gramza. OncoTargets and Therapy . 2008 (defa)
  • [3] Preparation with Recombinant Human Thyroid-Stimulating Hormone for Thyroid Remnant Ablation with ^sup 131^I Is Associated with Lowered Radiotoxicity[J] . Rosário,Pedro Weslley,Borges,Michelle Aparecida Ribeiro,Purisch,Saulo. The Journal of Nuclear Medicine . 2008 (11)
  • [4] Recombinant human TSH-assisted radioactive iodine remnant ablation achieves short-term clinical recurrence rates similar to those of traditional thyroid hormone withdrawal
    Tuttle, R. Michael
    Brokhin, Matvey
    Omry, Gal
    Martorella, Andrew J.
    Larson, Steven M.
    Grewal, Ravinder K.
    Fleisher, Martin
    Robbins, Richard J.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (05) : 764 - 770
  • [5] Recombinant human thyroid-stimulating hormone is effective for radioiodine ablation of post-surgical thyroid remnants
    Barbaro, Danielle
    Boni, Giuseppe
    Meucci, Giuseppe
    Simi, Umberto
    Lapi, Paola
    Orsini, Paola
    Pasquini, Cristina
    Turco, Anna
    Mariani, Giuliano
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2006, 27 (08) : 627 - 632
  • [6] Radioiodine Ablation of Thyroid Remnants after Preparation with Recombinant Human Thyrotropin in Differentiated Thyroid Carcinoma: Results of an International, Randomized, Controlled Study[J] . F Pacini,P W. Ladenson,M Schlumberger,A Driedger,M Luster,R T. Kloos,S Sherman,B Haugen,C Corone,E Molinaro,R Elisei,C Ceccarelli,A Pinchera,R L. Wahl,S Leboulleux,M Ricard,J Yoo,N L. Busaidy,E Delpassand,H Hanscheid,R Felbinger,M Lassmann,C Reiners. The Journal of Clinical Endocrinology & Metaboli
  • [7] Recombinant human thyrotropin stimulation of fluoro-D-glucose positron emission tomography uptake in well-differentiated thyroid carcinoma
    Chin, BB
    Patel, P
    Cohade, C
    Ewertz, M
    Wahl, R
    Ladenson, P
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (01) : 91 - 95
  • [8] Radioiodine Treatment with 30 mCi after Recombinant Human Thyrotropin Stimulation in Thyroid Cancer: Effectiveness for Postsurgical Remnants Ablation and Possible Role of Iodine Content in l-Thyroxine in the Outcome of Ablation[J] . Daniele Barbaro,Giuseppe Boni,Giuseppe Meucci,Umberto Simi,Paola Lapi,Paola Orsini,Cristina Pasquini,Francesca Piazza,Marco Caciagli,Giuliano Mariani. The Journal of Clinical Endocrinology & Metabolism . 2003 (9)
  • [9] Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma
    Pacini, F
    Molinaro, E
    Castagna, MG
    Agate, L
    Elisei, R
    Ceccarelli, C
    Lippi, F
    Taddei, D
    Grasso, L
    Pinchera, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (08) : 3668 - 3673
  • [10] Recombinant human thyrotropin (rhTSH) aided radioiodine treatment for residual or metastatic differentiated thyroid cancer .2 Ma C,Xie J,Liu W,Wang G,Zuo S,Wang X,Wu F. Cochrane Database Syst Rev . 2010